Microvascular permeability in diabetes and insulin resistance

Microcirculation

Volumn 14, Issue 4-5, 2007, Pages 363-373

  Yuan, Sarah Y ^a   Breslin, Jerome W ^a   Perrin, Rachel ^a   Gaudreault, Nathalie ^a   Guo, Mingzhang ^a   Kargozaran, Hamed ^a   Wu, Mack H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AGEs (advanced glycation end products); Hyperglycemia; PKC (protein kinase C); VEGF (vascular endothelial growth factor)

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADVANCED GLYCATION END PRODUCT; CYTOKINE; DIACYLGLYCEROL; GROWTH FACTOR; INSULIN; POLYOL; PROTEIN KINASE C; ROSIGLITAZONE; VASCULOTROPIN;

BLOOD VESSEL PERMEABILITY; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DISEASE COURSE; FLUID RETENTION; GLUCOSE METABOLISM; HOMEOSTASIS; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; LUNG EDEMA; METABOLIC DISORDER; MICROCIRCULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PERIPHERAL EDEMA; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SIGNAL TRANSDUCTION;

CAPILLARY PERMEABILITY; DIABETES MELLITUS; HUMANS; INFLAMMATION; INSULIN RESISTANCE; METABOLIC NETWORKS AND PATHWAYS;

ANIMALIA;

EID: 34447342541     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1080/10739680701283091     Document Type: Review

References (99)

1. Aiello, L. P. (2002) The potential role of PKC β in diabetic retinopathy and macular edema. Surv of Ophthalmol, 47, pp. S263-S269.
2. Andersen, S. K., Gjedsted, J., Christiansen, C. and Tonnesen, E. (2004) The roles of insulin and hyperglycemia in sepsis pathogenesis. J Leukoc Biol, 75, pp. 413-421.
3. Antonetti, D. A., Lieth, E., Barber, A. J. and Gardner, T. W. (1999) Molecular mechanisms of vascular permeability in diabetic retinopathy. Sem Ophthalmol, 14, pp. 240-248.
4. Aramoto, H., Breslin, J. W., Pappas, P. J., Hobson 2nd, R. W. and Duran, W. N. (2004) Vascular endothelial growth factor stimulates differential signaling pathways in in vivo microcirculation. Am J Physiol Heart Circ Physiol, 287, pp. H1590-H1598.
5. Baron, A. D. (1996) The coupling of glucose metabolism and perfusion in human skeletal muscle. Diabetes, 45, pp. S105-S109.
6. Bates, D. O. and Harper, S. J. (2003) Regulation of vascular permeability by vascular endothelial growth factors. Vascul Pharmacol, 39, pp. 225-237.
7. Beals, C. C., Bullock, J., Jáuregui, E. R. and Durán, W. N. (1993) Microvascular clearance of macromolecules in skeletal muscle of spontaneously diabetic rats. Microvas Res, 45, pp. 11-19.
8. Bochicchio, G. V., Sung, J., Joshi, M., Bochicchio, K., Johnson, S. B., Meyer, W. and Scalea, T. M. (2005) Persistent hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma, 58, pp. 921-924.
9. Bohlen, H. G. (2004) Mechanisms for early microvascular injury in obesity and type II diabetes. Curr Hypertens Rep, 6, pp. 60-65.
10. Bonnardel-Phu, E., Wautier, J., Schmidt, A. M., Avila, C. and Vicaut, E. (1999) Acute modulation of albumin microvascular leakage by advanced glycation end products in microcirculation of diabetic rats in vivo. Diabetes, 48, pp. 2052-2058.
11. Brownlee, M. (2005) The pathobiology of diabetic complications: A unifying mechanism. Diabetes, 54, pp. 1615-1625.
12. Caldwell, R. B., Bartoli, M., Behzadian, M. A., el-Remessy, A EB, Al-Shabrawey, M., Platt, D. H., Liou, G. I. and Caldwell, R. W. (2005) Vascular endothelial growth factor and diabetic retinophathy: Role of oxidative stress. Curr Drug Targets, 6, pp. 511-524.
13. Chehade, J. M., Haas, M. J. and Mooradian, A. D. (2002) Diabetes-related changes in rat cerebral occluding and zonula occludens-1 (ZO-1) expression. Neurochem Res, 27, pp. 249-252.
14. Clark, M. G., Barrett, E. J., Wallis, M. G., Vincent, M. A. and Rattigan, S. (2002) The microvasculature in insulin resistance and type 2 diabetes. Sem Vascul Med, 2, pp. 21-31.
15. Clerk, L. H., Rattigan, S. and Clark, M. G. (2002) Lipid infusion impairs physiologic insulin-mediated capillary recruitment and muscle glucose uptake in vivo. Diabetes, 51, pp. 1138-1145.
16. Coggins, M., Lindner, J., Rattigan, S., Jahn, L., Fasy, E., Kaul, S. and Barrett, E. (2001) Physiologic hyperinsulinemia enhances human skeletal muscle perfusion by capillary recruitment. Diabetes, 50, pp. 2682-2690.
17. Colantuoni, A., Lapi, D., Paterni, M. and Marchiafava, P. L. (2005) Protective effects of insulin during ischemia-reperfusion injury in hamster cheek pouch microcirculation. J Vasc Res, 42, pp. 55-66.
18. Curtis, T. M. and Scholfield, C. N. (2004) The role of lipids and protein kinase Cs in the pathogenesis of diabetic retinophathy. Diabetes Metab Res Rev, 20, pp. 28-43.
19. Curry, F. E. and Adamson, R. H. (1999) Transendothelial pathways in venular microvessels exposed to agents which increase permeability: The gaps in our knowledge. Microcirculation, 6, pp. 3-5.
20. Davidson, M. K., Patricia, K. R., Glick, G. G., Hoffman, L. H., Chang, M. S. and Haselton, F. R. (2000) Reduced expression of the adherens junction protein cadherin-5 in a diabetic retina. Am J Ophthalmol, 129, pp. 267-296.
21. Dell'Omo, G., Penno, G., Pucci, L., Mariani, M., Prato, S. D. and Pedrinelli, R. (2004) Abnormal capillary permeability and endothelial dysfunction in hypertension with comorbid metabolic syndrome. Atherosclerosis, 172, pp. 383-389.
22. Esposito, C., Gerlach, H., Brett, J., Stern, D. and Vlassara, H. (1989) Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med, 170, pp. 1387-1407.
23. Farese, R. V. (2001) Insulin-sensitive phospholipids signaling systems and glucose transport: Update II. Exp Biol Med, 226, pp. 283-295.
24. Ferro, T., Neumann, P., Gertzberg, N., Clements, R. and Johnson, A. (2000) Protein kinase C-α mediates endothelial barrier dysfunction induced by TNF-α. Am J Physiol Lung Cell Mol Phyisol, 278, pp. L1107-L1117.
25. Frisbee, J. C. (2005) Reduced nitric oxide bioavailability contributes to skeletal muscle microvessel rarefaction in the metabolic syndrome. Am J Physiol Regul Integr Comp Physiol, 289, pp. R307-R316.
26. Gearhart, M. M. and Parbhoo, S. K. (2006) Hyperglycemia in the critically ill patient. AACN Clin Issues, 1, pp. 50-55.
27. Gaudreault, N., Santure, M., Pitre, M., Nadeau, A., Marette, A. and Bachelard, H. (2001) Effect of insulin on regional blood flow and glucose uptake in Wistar and Sprague Dawley rats. Metabolism, 50, pp. 65-73.
28. Goldin, A., Beckman, J. A., Schmidt, A. M. and Creager, M. A. (2006) Advanced glycation end products: Sparking the development of diabetic vascular injury. Circulation, 114, pp. 597-605.
29. Goodfellow, J. (1997) Microvascular heart disease in diabetes mellitus. Diabetologia, 40, pp. S130-S133.
30. Gudbjornsdottir, S., Sjostrand, M., Strindberg, L. and Lonnroth, P. (2005) Decreased muscle capillary permeability surface area in type 2 diabetic subjects. J Clin Endocrinol Metab, 90, pp. 1078-1082.
31. Guo, M., Wu, M. H., Korompai, F. and Yuan, S. Y. (2003) Upregulation of PKC genes and isozymes in cardiovascular tissues during early stages of experimental diabetes. Physiol Genomics, 12, pp. 139-146.
32. Harrington, E. O., Brunelle, J. L., Shannon, C. J., Kim, E. S., Mennella, K. and Rounds, S. (2003) Role of protein kinase C isoforms in rat epididymal microvascular endothelial barrier function. Am J Respir Cell Mol Biol, 28, pp. 626-636.
33. Haselton, F. R., Dworska, E. J. and Hoffman, L. H. (1998) Glucose-induced increase in paracellular permeability and disruption of beta-receptor signaling in retinal endothelium. Invest Ophthalmol Vis Sci, 39, pp. 1676-1684.
34. King, G. L. (2004) Microvascular complications of diabetes. Endocrinol Metab Clin N Am, 33, pp. 215-238.
35. Hempel, A., Maasch, C., Heintze, U., Lindschau, C., Dietz, R., Luft, F. C. and Haller, H. (1997) High glucose concentrations increase endothelial cell permeability via activation of protein kinase C alpha. Circ Res, 81, pp. 363-371.
36. Hilsted, J. and Christensen, N. J. (1992) Dual effect of insulin on plasma volume and transcapillary albumin transport. Diabetologia, 35, pp. 99-103.
37. Huber, J. D., Van Gilder, R. L. and Houser, K. A. (2006) Streptozotocin-induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats. Am J Phyisol Heart Circ Phyisol, 291, pp. H2660-H2668.
38. Idris, I., Gray, S. and Donnelly, R. (2001) Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes. Diabetologia, 44, pp. 659-673.
39. Idris, I., Gray, S. and Donnelly, R. (2003) Rosiglitazone and pulmonary oedema: An acute dose-dependent effect on human endothelial cell permeability. Diabetologia, 46, pp. 288-290.
40. Jeschke, M. G., Klein, D. and Herndon, D. N. (2004) Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann Surg, 239, pp. 553-560.
41. Joy, S. V., Scates, A. C., Bearelly, S., Dar, M., Taulien, C. A., Goebel, J. A. and Cooney, M. J. (2005) Ruboxistaurin, a protein kinase C β inhibitor, as an emerging treatment for diabetes microvascular complications. Ann Pharmacother, 39, pp. 1693-1699.
42. Kalambokis, G. N., Tsatsoulis, A. A. and Tsianos, E. V. (2004) The edematogenic properties of insulin. Am J Kidney Dis, 44, pp. 575-590.
43. Kang, N., Alexander, G., Park, J. K., Maasch, C., Buchwalow, I., Luft, F. C. and Haller, H. (1999) Differential expression of protein kinase C isoforms in streptozotocin-induced diabetic rats. Kidney Int, 6, pp. 1737-1750.
44. Kornerup, K., Nordestgaard, B. G., Feldt-Rasmussen, B., Borch-Johnses, K., Jensen, K. S. and Jensen, J. S. (2002) Transvascular low-density lipoprotein transport in patients with diabetes mellitus (type 2): A noninvasive in vivo isotope technique. Arterioscler Thromb Vasc Biol, 22, pp. 1168-1174.
45. Koya, D. and King, G. L. (1998) Protein kinase C activation and the development of diabetic complications. Diabetes, 47, pp. 859-866.
46. Laakso, M., Edelman, S., Brechtel, G. and Baron, A. D. (1990) Decreased effects of insulin to stimulate skeletal muscle blood flow in obese man. J Clin Invest, 85, pp. 1844-1852.
47. Laird, A. M., Miller, P. R., Kilgo, P. D., Meredith, J. W. and Chang, M. C. (2004) Relationship of early hyperglycemia to mortality in trauma patients. J Trauma, 56, pp. 1058-1062.
48. Langouche, L., Vanhorebeek, I., Vlasselaers, D., Perre, S. V., Wouters, P. J., Skogstrand, K., Hansen, T. K. and Berghe, G Van den (2005) Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest, 115, pp. 2277-2286.
49. Liu, X., Wang, J., Takeda, N., Binaglia, L., Pangia, V. and Dhalla, N. S. (1999) Changes in cardiac protein kinase C activities and isozymes in streptozotocin-induced diabetes. Am J Physiol, 277, pp. E798-E804.
50. McDonagh, P. F. and Hokama, J. Y. (2000) Microvascular perfusion and transport in the diabetic heart. Microcirculation, 7, pp. 163-181.
51. Moore, T. C., Moore, J., Kaji, Y., Frizzell, N., Usui, T., Poulaki, V., Cambell, I. L., Stitt, A. W., Gardiner, T. A., Archer, D. B. and Adamis, A. P. (2003) The role of advanced glycation end products in retinal microvascular leukostasis. Invest Ophthalmol Vis Sci, 44, pp. 4457-4464.
52. Newton, A. C. (2001) Protein kinase C: Structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. Chem Rev, 101, pp. 2353-2364.
53. Nobe, K., Miyatake, M., Sone, T. and Honda, K. (2006) High-glucose-altered endothelial cell function involves both disruption of cell-to-cell connection and enhancement of force development. J Pharmacol Exp Ther, 318, pp. 530-539.
54. Oomen, P HN, Kant, G. D., Dullaart, R PF, Reitsma, W. D. and Smit, A. J. (2002) Acute hyperglycemia and hyperinsulinemia enhance vasodilation in type 1 diabetes mellitus without increasing capillary permeability and inducing endothelial dysfunction. Microvascular, 63, pp. 1-9.
55. Otero, K., Martinez, F., Beltran, A., Gonzalez, D., Herrera, B., Quintero, G., Delgado, R. and Rojas, A. (2001) Albumin-derived advanced glycation end-products trigger the disruption of the vascular endothelial cadherin complex in cultured human and murine endothelial cells. Biochem J, 359, pp. 567-574.
56. Plante, G. E., Perreault, M., Lanthier, A., Marette, A. and Maheux, P. (2003) Reduction of endothelial NOS and bradykinin-induced extravasation of macromolecules in skeletal muscle of the fructose-fed rat model. Cardiovasc Res, 59, pp. 963-970.
57. Rask-Madsen, C. and King, G. L. (2004) Proatherosclerotic mechanisms involving protein kinase C in diabetes and insulin resistance. Arterioscler Thromb Vasc Biol, 25, pp. 487-496.
58. Rath, S., Kalogeris, T., Mai, N., Zibari, G., Alexander, J. S., Lefer, D. and Turnage, R. H. (2006) Insulin prevents oxidant-induced endothelial cell barrier dysfunction via nitric oxide-dependent pathway. Surgery, 139, pp. 82-91.
59. Rennings, A. J., Smits, P., Stewart, M. W. and Tack, C. J. (2006) Fluid retention and vascular effects of rosiglitazone in obese, insulin-resistant nondiabetic subjects. Diabetes Care, 29, pp. 581-587.
60. Salameh, A., Zinn, M. and Dhein, S. (1997) High D-glucose induces alterations of endothelial cell structure in a cell-culture model. J Cardiovascul Pharmacol, 30, pp. 182-190.
61. Sampathkumar, R., Balasubramanyam, M., Rema, M., Premanand, C. and Mohan, V. (2005) A novel advanced glycation index and its association with diabetes and microangiopathy. Metabolism, 54, pp. 1002-1007.
62. Sanchez, F. A., Savalia, N. B., Duran, R. G., Lal, B. K., Boric, M. P. and Duran, W. N. (2006) Functional significance of differential eNOS translocation. Am J Physiol Heart Circ Physiol, 291, pp. H1058-H1064.
63. Sasaki, R., Whitt, S. P. and Huxley, V. H. (2006) Permeability response of the rat mesenteric microvasculature to insulin. Clin Hemorheol Microcirc, 34, pp. 259-263.
64. Schmidt, A. M., Yan, S. D., Yan, S. F. and Stern, D. M. (2000) The biology of the receptor for advanced glycation end products and its ligands. Biochim Biophys Acta, 1498, pp. 99-111.
65. Scott, J. A. and King, G. L. (2004) Oxidative stress and antioxidant treatment in diabetes. Ann NY Acad Sci, 1031, pp. 204-213.
66. Shore, A. C. (2002) The microvasculature in type 1 diabetes. Sem Vasc Med, 2, pp. 9-20.
67. Sotiropoulos, K. B., Clermont, A., Yasuda, Y., Rask-Madsen, C., Mastumoto, M., Takahashi, J., Vecchia, K. D., Kondo, T., Aiello, L. P. and King, G. L. (2006) Adipose-specific effect of rosiglitazone on vascular permeability and protein kinase C activation: Novel mechanism for PPARγ agonist's effects on edema and weight gain. FASEB, 20, pp. E367-E380.
68. St-Pierre, P., Bouffard, L., Papirakis, M-E and Maheux, P. (2006) Increased extravasation of macromolecules in skeletal muscles of the Zucker rat model. Obesity, 5, pp. 787-793.
69. St-Pierre, P., Bouffard, L. and Maheux, P. (2004) Rosiglitazone increases extravasation of macromolecules and endothelial nitric oxide synthase in skeletal muscles of the fructose-fed rat model. Biochem Pharm, 67, pp. 1997-2004.
70. Stenina, O. I. (2005) Regulation of vascular genes by glucose. Curr Pharm Des, 11, pp. 2367-2381.
71. Stepp, D. W. (2006) Impact of obesity and insulin resistance on vasomotor tone: Nitric oxide and beyond. Clin Exp Pharm Phys, 33, pp. 407-414.
72. Stokes, K. Y., Cooper, D., Tailor, A. and Granger, D. N. (2002) Hypercholesterolemia promotes inflammation and microvascular dysfunction: Role of nitric oxide and superoxide. Free Radic Biol Med, 33, pp. 1026-1036.
73. Sun, H., Breslin, J., Zhu, J., Yuan, S. Y. and Wu, M. H. (2006) Rho GTPase in VEGF-induced microvasular hyperpermeability. Microcirculation, 13, pp. 1-11.
74. Tilton, R. G. (2002) Diabetic vascular dysfunction: Links to glucose-induced reductive stress and VEGF. Microscopy Res Tech, 57, pp. 390-407.
75. Tinsley, J. H., Teasdale, N. R. and Yuan, S. Y. (2004) Involvement of PKC-delta and PKD in pulmonary microvascular endothelial cell hyperpermeability (2004). Am J Physiol Cell Physiol, 286, pp. C105-C111.
76. Tomlinson, D. R. (1999) Mitogen-activated protein kinases as glucose transducers for diabetic complications. Diabetologia, 42, pp. 1271-1281.
77. Tooke, J. E. (1995) Microvascular function in human diabetes. Diabetes, 44, pp. 721-726.
78. Tuttle, K. R., Bakris, G. L., Toto, R. D., McGill, J. B. and Anderson, P. W. (2005) The effect of ruboxistaurin on nephropathy in type 2 diabetes. Diabetes Care, 28, pp. 2686-2690.
79. Valensi, P., Cohen-Boulakia, F., Attali, J. R. and Behar, A. (1997) Changes in capillary permeability in diabetic patients. Clin Hermorheol Microcirc, 17, pp. 389-394.
80. Van, den Berhe, G. (2004) How does blood glucose control with insulin save lives in intensive care. J Clin Invest, 114, pp. 1187-1195.
81. Van, den, Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P., Milants, I., Wijngaerden, E. V., Bobbaers, H. and Bouillon, R. (2006) Intensive insulin therapy in the medical ICU. N Engl J Med, 254, pp. 449-461.
82. Viberti, G. (2004) Thiazolidinediones - benefits on microvascular complications of type 2 diabetes. J Diabetes Complications, 19, pp. 168-177.
83. Vincent, M. A., Montagnani, M. and Quon, M. J. (2003) Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium. Curr Diab Rep, 3, pp. 279-288.
84. Vink, G. and Dulling, B. (2000) Capillary endothelial surface layer selectively reduces plasma solute distribution volume. Am J Phyisol Heart Circ Phyisol, 278, pp. H285-H289.
85. Vinores, S. A., Derevjankik, N. L., Mahlow, J., Berkowitz, B. A. and Wilson, C. A. (1998) Electron microscopic evidence for the mechanism of blood-retinal barrier breakdown in diabetic rabbits: Comparison with magnetic resonance imaging. Pathol Res Pract, 194, pp. 497-505.
86. Ward, B. J. and al-Haboubi, H. A. (1997) Structural changes in the cardiac microvasculature of the rat in response to acute high glucose levels: A comparison with diabetes. Microcirculation, 4, pp. 429-437.
87. Wautier, J. L., Zoukourian, C., Chappey, O., Wautier, M. P., Guillausseau, P. J., Cao, R., Hori, O., Stern, D. and Schmidt, A. M. (1996) Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J Clin Invest, 97, pp. 238-243.
88. Wolf, B. A., Williamson, J. R., Easom, R. A., Chang, K., Sherman, W. R. and Turk, J. (1991) Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels. J Clin Invest, 87, pp. 31-38.
89. Huang, Q., Yuan, Y. and Granger, H. J. (1996) VEGF induces NO-dependent hyperpermeability in coronary venules. Am J Physiol, 271, p. H2735.
90. Wu, M. H., Yuan, S. Y., Zawieja, D. C., Tinsley, J. H. and Granger, H. J. (1999) Role of phospholipase C, protein kinase C and calcium in VEGF-induced venular hyperpermeability. Am J Physiol, 276, pp. H535-H542.
91. Wu, M. H., Yuan, S. Y. and Granger, H. J. (2005) The protein kinase MEK1/ 2 mediate VEGF- and histamine-induced hyperpermeability in porcine coronary venules. J Physiol (London), 563, pp. 95-104.
92. Wu, M. H. (2005) Endothelial focal adhesion and barrier function. J Physiol (London), 569, pp. 359-366.
93. Yamaji, T., Fukuhara, T. and Kinoshita, M. (1993) Increased capillary permeability to ablumin in diabetic rat myocardium. Circ Res, 72, pp. 947-957.
94. Yendamuri, S., Fulda, G. J. and Tinkoff, G. H. (2003) Admission hyperglycemia as a prognostic indicator in trauma. J Trauma, 55, pp. 33-38.
95. Yu, P. K., Yu, D. Y., Cringle, S. J. and Su, E. N. (2005) Endothelial F-actin cytoskeleton in the retinal vasculature of normal and diabetic rats. Curr Eye Res, 30, pp. 279-290.
96. Yuan, S. Y., Ustinova, E. E., Wu, H. M., Tinsley, J. H., Korompai, F. L. and Taulman, A. C. (2000) PKC activation contributes to microvascular barrier dysfunction in the heart at early stages of diabetes. Circ Res, 87, pp. 412-417.
97. Yuan, S. Y. (2000) Signal transduction pathways in enhanced microvascular permeability. Microcirculation, 7, pp. 395-403.
98. Yuan, S. Y. (2003) Protein kinase signaling in the modulation of microvascular permeability. Vasc Pharmacol, 39, pp. 213-223.
99. Yuan, S. Y. (2006) New insights into eNOS signaling in microvascular permeability. Am J Physiol Heart Circ Physiol, 291, pp. H1029-H1031.